Salomon Azoulay, Chief Medical Officer at MBX Biosciences, Inc. (MBX), sold 231 shares at $29.54 ($7K) on 2026-05-06, disclosed to the SEC on 2026-05-08.
Open-market sale of $7k MBX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |